rebiotics and probiotics are considered natural alternatives to dietary antibiotics in animal production. Plant extracts and yeast cell walls are mannose-rich products that can be used as substrate for adhesion of Gram-negative bacteria. We assessed whether the structure of these saccharides is relevant to develop their role as prebiotics and therefore, their suitability to be used as alternatives to antibiotics to prevent intestinal infections in pigs. The prebiotic functionality of β-galactomannan (βGM), mannanoligosaccharide from yeast Saccharomyces cerevisiae (Mannan SC) and monosaccharide D-Mannose were studied in porcine intestinal epithelial cells (IPI-2I) challenged with Salmonella enterica ser. Typhimurium. Results showed that in vitro challenge with Salmonella induces the secretion of proinflammatory cytokine IL6 and chemokine CXCL8 compared with control without infection. Both βGM and Mannan SC, attenuate Salmonella-induced secretion of IL6 and CXCL8. Interestingly, cells treated with D-mannose showed similar levels of proinflammatory IL6 and CXCL8 compared with the control of infection. These data suggest that prebiotic role of βGM is related to its oligosaccharide structure.
Introduction
Livestock animals are subjected to a huge sort of stress factors, such as environmental conditions, animal management or diets that may disrupt the intestinal ecosystem and increase the risk of pathogenic infections. In the swine industry, Oligosaccharide structure determines prebiotic role of β-galactomannan against Salmonella enterica ser. Typhimurium in vitro Roger transition from the liquid to a solid diet during weaning and post-weaning are critical processes due to an important decrease of feed intake, impairing animal performance, immune function, microbiota and therefore, gut homeostasis. 1 Concerning the immune system, these performance stages lead to the end of transference of passive maternal immunity from the sows to the piglets which still have an immature or developing immune system. 2 This means that piglets become highly susceptible to intestinal pathogens such as enterotoxigenic E. coli (ETEC) or Salmonella enterica ser. Typhimurium (hereafter Salmonella).
Antibiotic growth promoters (AGPs) have been extensively used as dietary additives to minimize the risk of infections, especially during the critical periods of animal production, like weaning. However, after European ban of AGPs (EC 1831/2003) several studies proposed the use of probiotics and prebiotics as natural alternatives to AGPs. 1 In that sense, the health benefits of probiotics and prebiotics have been widely accepted as gut microbiota stabilizers because they are believed to avoid pathogenic colonization and therefore improving animal welfare. 3, 4 Our group recently published in vitro results that demonstrated the potential of probiotic Saccharomyces cerevisiae var Boulardii and prebiotic β-galactomannan (βGM) to prevent intestinal infections by E. coli 5 and Salmonella 6 in pigs. Here, we aimed to extend the knowledge about the prebiotic role of βGM against Salmonella challenge according to its polysaccharide structure. In addition to the residue composition, prebiotic functionality is determined by the size and molecular structure of the saccharides. 13 Here, we evaluated functionality of βGM according to their polysaccharide structure. We compared βGM to monosaccharide D-mannose and to another mannan oligosaccharide purified from Saccharomyces cerevisiae yeast (Mannan SC) at a final concentration of 10 μg/ml. We observed that in vitro challenge with Salmonella induces the secretion of proinflammatory cytokine IL6 (4-fold increase: 224 vs. 897 pg/ml; Figure 1A ) and chemokine CXCL8 (2-fold increase: 2645 vs. 5192 pg/ml; Figure 1B ) compared with control without infection. Both, βGM and Mannan SC showed a 40% reduction of Salmonella-induced secretion of IL6 (897 vs. 563 and 585 pg/ml, Figure 1A ). Concerning CXCL8, βGM reduce chemokine secretion by 30% (5192 vs 3697 pg/ml; Figure 1B) . However, Mannan SC shows a trend to reduce CXCL8 secretion induced by Salmonella (Fig. 1B) . Interestingly, the secretion of proinflammatory IL6 and CXCL8 in IECs treated with monosaccharide D-mannose was similar to the control of infection ( Fig. 1A  and B In this regard, our previous in vitro works showed that Scb has a higher antiinflammatory role in ETEC infections. 5 In contrast, βGM is a potent prophylactic agent against Salmonella infections. Therefore, the preference of the use of each Mannan derived products, such as Scb and βGM, are widely accepted to prevent Salmonella colonization by binding to the adhesin Fim H of the type I fimbriae. The interaction of probiotic Scb and prebiotic βGM was already confirmed in our previous work. 6 However, enterotoxigenic E. coli K88, which is one on the most important causes of neonatal and postweaning diarrhea (PWD) in piglets, bears type IV fimbriae or pilli. 10 The latter has been described as mannose resistant to erythrocyte agglutination test in the presence of D-Mannose (5%). 11 Nevertheless, the K88 adhesins (ab, ac and ad) bind to β-galactose residues of receptors of syalic glycoprotein and to neutral glycosphingolipids expressed on the surface of the intestinal mucosa. 12 The presence of β-galactose in Scb and βGM may mimic host receptor for K88 adhesin 4 and therefore inhibit ETEC attachement to cell surface.
Results and Discussion
Many intestinal pathogenic strains of Salmonella and E. coli share type I fimbriae, although from different evolutionary origin, which have high affinity for mannose residues of glycoproteins present on cell surface of the host. 4, 8, 9 The recognition of these residues leads to bacterial adherence to enterocyte surface and intestinal colonization by the pathogen. Our recent articles showed how probiotic strain of Saccaromyces cerevisiae var Boulardii (Scb) and a recently developed prebiotic β-galactomannan (βGM), derived from fruit seed of the Ceratonia silliqua tree, inhibit in vitro adhesion of Salmonella 6 and ETEC 5 to pig intestinal cell line IPI-2I. Indeed, both products decreased the overall proinflammatory profile induced by ETEC or Salmonella, with the least expenditure of resources for innate immune response to deal with each pathogen. Salmonella was used at MOI = 4 as previously described. 6 After 3 h of host cellpathogen assay performed as described before, 75μg/ml of Gentamycin (SigmaAldrich) were added to each well to avoid bacterial overgrowth. After 24 h, supernatants were sampled and stored at -80°C until analysis.
Determination of cytokine production. Cytokine protein determination in the culture supernatant was performed by enzyme-linked immunosorbent assays (ELISAs). Swine IL-6 and CXCL8 DuoSet ELISA kits (R&D Systems, Vitro SP) were used according to manufacturer's recommendations.
Statistical analysis. All statistical analyses were performed using GLM procedure (PROC GLM) by SAS Software version 9.1.3 (SAS institute). Means for protein secretion were considered in a 2*3 factorial design (two infection levels * 3 experimental treatments) with Duncan's post-test for group analysis. The P value ≤ 0.05 was considered to be significant. Superscript letters are used to designate statistical significance: Bars with different superscript letters are significantly different (p < 0.05) and bars with same superscript letters indicate no statistical difference (n.s).
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(Invitrogen, Spain) supplemented with 10% FCS (Invitrogen), insulin 10 μg/ml (Sigma-Aldrich, Saint-Quentin, France). In all experiments, cells were cultured in 6-well plates (Nunc, Labclinics, Spain) to confluence. Before the addition of pre/ probiotics and/or infection, cells were washed three times and the cell culture was replaced with DMEM media supplemented with insulin 10 μg/ml (SigmaAldrich). Cells were used between passages 30 and 70 and periodically tested to avoid Mycoplasma contamination (MycoAlert ® Mycoplasma Detection Kit, Lonza).
Experimental treatments and prebiotic preparation. To assess the functionality of mannans according to their structure we compared the prebiotic βGM (Salmosan © , patent WO2009/144070 A2, licensed to Industrial Técnica Pecuaria, ITPSA, Barcelona, Spain) to another mannanoligosaccharide purified from Saccharomyces cerevisiae (Mannan SC, Sigma) and to D-Mannose monosaccharide (Sigma-Aldrich) in relation to a negative control (medium).
Prebiotic βGM, Mannan SC and D-mannose were diluted in DMEM glutamax (1 mg/ml), vortexed and incubated 30 min at 37°C. Immediately before the Salmonella infection, βGM, Mannan SC and D-mannose were respectively added to each well at 10μg/ml.
Host cell-pathogen assay. Pathogenic Salmonella enterica serovar Typhimurium (Salmonella) with antigenic formulae (4,12:i:1,2), resistant to ampicillin, chloramphenicol, streptomycin, sulfonamide and tetracycline was provided by Dr Ignacio Badiola from Centre Recerca en Sanitat Animal (CReSA, IRTA-UAB, Bellaterra, Spain). Aliquots of Salmonella were provided in bacterial cryo-preservers (Technical Service Consultants, Ferrer International, Spain) and stored at -80°C until use. Before infection IEC cells, a single Salmonella cryo-preserver was added to 20 ml of Luria-Bertani media (LB) and cultured for 3-4 h at 37°C with 180 rpm rotational agitation (Multitron HT, Infors). For infection, Salmonella was used during the exponential growth phase as determined by absorbance at 600 nm. probiotic or prebiotic additive as a dietary alternative to AGPs, should be determined, if possible, according to the specific conditions of each farm. This means the prevalence of ETEC or Salmonella of each productive facility or region. In that sense, considering that ETEC infections often occur during weaning, 19 while Salmonella usually colonizes post-weaning and finishing growing pigs, 20 to enrich diets with Scb at early stages to prevent ETEC infections and with βGM to reduce Salmonella prevalence at final growing stages should be considered. In addition, we hypothesize that the prebiotic βGM may enhance probiotic Scb survival and colonization of the intestinal tract improving host health. 21 Future studies should determine the suitability to combine βGM and Scb to become a symbiotic additive to prevent intestinal infections.
Nowadays in EU, products such as Mannan SC and βGM are not authorized as zootechnical feed additives under the commission regulation (EC) 1831/2003. 22 In the future, both products could be authorized following concepts described in the opinion of EFSA (see ref. 23) concerning potential new categories of zootechnical feed additives. In this case it would be additives which improve product quality as "Microbial contamination controllers." However, today it is also possible to introduce them in the European feed legislation according to the regulation (EC) 767/2009 24 where there is a description of how ingredients can be used for particular purposes.
In conclusion, we demonstrated that oligosaccharide structure is crucial for mannans to develop their prebiotic role to inhibit pathogenic adhesion and therefore to reduce proinflamatory immune response induced by the pathogen.
Methods

Intestinal epithelial cell culture (IECs).
The porcine small intestine epithelial cell line IPI-2I (ECACC 93100622) was established from the ileum of an adult boar (SLAd/d haplotype). 7 IPI-2I cells were maintained in DMEM glutamax
